Celyad Oncology will give a presentation at the HC Wainwright Global Investment Conference – 05/17/2022 at 22:01

Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on the research and development of CAR T (Chimeric Antigen Receptor) cell therapies based on cells for the treatment of cancer, announced today that the Company will participate virtually in the upcoming HC Wainwright Global Investment Conference which will take place from May 23-26, 2022.

The Society’s presentation will be available, on demand, on the HC Wainwright Conference portal; from Tuesday, May 24, 2022 at 1:00 p.m. CET.

Source link -86